Subscribe Sign In Register

Premium

Joseph Edelman’s Perceptive Fund Surges in 2017

The Perceptive Life Sciences Fund’s portfolio of biotech and other life science companies has blown away the stock market averages — with a lot of volatility along the way.

By Stephen Taub Stephen Taub
May 11, 2017
2017-05-alpha-stephen-taub-joseph-edelman-main.jpg
2017-05-alpha-stephen-taub-joseph-edelman-article.jpg
Joseph Edelman, chief executive officer of Perceptive Advisors LLC (Photo Credit: Chris Goodney/Bloomberg)

The Perceptive Life Sciences Fund is off to another strong start after taking a pause last year.

This

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Perceptive Life Sciences Joseph Edelman
Related
Art_RAcapital_0423.jpg
Hedge Funds
RA Capital’s Buying Spree
Stephen Taub
April 23, 2024
discoverycapital_0422.jpg
Hedge Funds
Discovery Is Off to a Strong Start
Stephen Taub
April 22, 2024
Bitcoin Risk Management
Sponsored
Bitcoin Risk Management Moves to the Fore